Cargando…

Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics

OBJECTIVE: To evaluate the impact of glucose variability on the relationship between the GRI and other glycemic metrics in a cohort of pediatric and adult patients with type 1 diabetes (T1D) using intermittent scanning continuous glucose monitoring (isCGM). METHODS: We performed a cross-sectional st...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-López, Paloma, Férnandez-Velasco, Pablo, Bahillo-Curieses, Pilar, de Luis, Daniel, Díaz-Soto, Gonzalo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618378/
https://www.ncbi.nlm.nih.gov/pubmed/37695452
http://dx.doi.org/10.1007/s12020-023-03511-7
_version_ 1785129762791882752
author Pérez-López, Paloma
Férnandez-Velasco, Pablo
Bahillo-Curieses, Pilar
de Luis, Daniel
Díaz-Soto, Gonzalo
author_facet Pérez-López, Paloma
Férnandez-Velasco, Pablo
Bahillo-Curieses, Pilar
de Luis, Daniel
Díaz-Soto, Gonzalo
author_sort Pérez-López, Paloma
collection PubMed
description OBJECTIVE: To evaluate the impact of glucose variability on the relationship between the GRI and other glycemic metrics in a cohort of pediatric and adult patients with type 1 diabetes (T1D) using intermittent scanning continuous glucose monitoring (isCGM). METHODS: We performed a cross-sectional study of 202 patients with T1D under intensive insulin treatment (25.2% CSII) using isCGM. Clinical, metabolic, and glycemic metrics were collected, and the GRI was calculated with its hypoglycemia (CHypo) and hyperglycemia (CHyper) components. The correlation between the GRI and other classical glycometrics in relation to the coefficient of variation (CV) was evaluated. RESULTS: A total of 202 patients were included (53% male; 67.8% adults) with a mean age of 28.6 ± 15.7 years and 12.5 ± 10.9 years of T1D evolution (TIR 59.0 ± 17.0%; CV 39.8 ± 8.0%; GMI 7.3 ± 1.1%). The mean GRI was 54.0 ± 23.3 with a CHypo and CHyper component of 5.7 ± 4.8 and 23.4 ± 14.3, respectively. A strong negative correlation was observed between the GRI and TIR (R = −0.917; R(2) = 0.840; p < 0.001), showing differences when dividing patients with low glycemic variability (CV < 36%) (R = −0.974; R(2) = 0.948; p < 0.001) compared to those with greater CV instability (≥36%) (R = −0.885; R(2) = 0.784; p < 0.001). The relationship of GRI with its two components was strongly positive with CHyper (R = 0.801; R(2) = 0.641; p < 0.001) and moderately positive with CHypo (R = 0.398; R(2) = 0.158; p < 0.001). When the GRI was evaluated with the rest of the classic glycemic metrics, a strong positive correlation was observed with HbA1c (R = 0.617; R(2) = 0.380; p < 0.001), mean glucose (R = 0.677; R(2) = 0.458; p < 0.001), glucose standard deviation (R = 0.778; R(2) = 0.605; p < 0.001), TAR > 250 (R = 0.801; R(2) = 0.641; p < 0.001), and TBR < 54 (R = 0.481; R(2) = 0.231; p < 0.001). CONCLUSIONS: The GRI correlated significantly with all the glycemic metrics analyzed, especially with the TIR. Glycemic variability (GV) significantly affected the correlation of the GRI with other parameters and should be taken into consideration.
format Online
Article
Text
id pubmed-10618378
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-106183782023-11-02 Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics Pérez-López, Paloma Férnandez-Velasco, Pablo Bahillo-Curieses, Pilar de Luis, Daniel Díaz-Soto, Gonzalo Endocrine Original Article OBJECTIVE: To evaluate the impact of glucose variability on the relationship between the GRI and other glycemic metrics in a cohort of pediatric and adult patients with type 1 diabetes (T1D) using intermittent scanning continuous glucose monitoring (isCGM). METHODS: We performed a cross-sectional study of 202 patients with T1D under intensive insulin treatment (25.2% CSII) using isCGM. Clinical, metabolic, and glycemic metrics were collected, and the GRI was calculated with its hypoglycemia (CHypo) and hyperglycemia (CHyper) components. The correlation between the GRI and other classical glycometrics in relation to the coefficient of variation (CV) was evaluated. RESULTS: A total of 202 patients were included (53% male; 67.8% adults) with a mean age of 28.6 ± 15.7 years and 12.5 ± 10.9 years of T1D evolution (TIR 59.0 ± 17.0%; CV 39.8 ± 8.0%; GMI 7.3 ± 1.1%). The mean GRI was 54.0 ± 23.3 with a CHypo and CHyper component of 5.7 ± 4.8 and 23.4 ± 14.3, respectively. A strong negative correlation was observed between the GRI and TIR (R = −0.917; R(2) = 0.840; p < 0.001), showing differences when dividing patients with low glycemic variability (CV < 36%) (R = −0.974; R(2) = 0.948; p < 0.001) compared to those with greater CV instability (≥36%) (R = −0.885; R(2) = 0.784; p < 0.001). The relationship of GRI with its two components was strongly positive with CHyper (R = 0.801; R(2) = 0.641; p < 0.001) and moderately positive with CHypo (R = 0.398; R(2) = 0.158; p < 0.001). When the GRI was evaluated with the rest of the classic glycemic metrics, a strong positive correlation was observed with HbA1c (R = 0.617; R(2) = 0.380; p < 0.001), mean glucose (R = 0.677; R(2) = 0.458; p < 0.001), glucose standard deviation (R = 0.778; R(2) = 0.605; p < 0.001), TAR > 250 (R = 0.801; R(2) = 0.641; p < 0.001), and TBR < 54 (R = 0.481; R(2) = 0.231; p < 0.001). CONCLUSIONS: The GRI correlated significantly with all the glycemic metrics analyzed, especially with the TIR. Glycemic variability (GV) significantly affected the correlation of the GRI with other parameters and should be taken into consideration. Springer US 2023-09-11 2023 /pmc/articles/PMC10618378/ /pubmed/37695452 http://dx.doi.org/10.1007/s12020-023-03511-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Pérez-López, Paloma
Férnandez-Velasco, Pablo
Bahillo-Curieses, Pilar
de Luis, Daniel
Díaz-Soto, Gonzalo
Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics
title Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics
title_full Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics
title_fullStr Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics
title_full_unstemmed Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics
title_short Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics
title_sort impact of glucose variability on the assessment of the glycemia risk index (gri) and classic glycemic metrics
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618378/
https://www.ncbi.nlm.nih.gov/pubmed/37695452
http://dx.doi.org/10.1007/s12020-023-03511-7
work_keys_str_mv AT perezlopezpaloma impactofglucosevariabilityontheassessmentoftheglycemiariskindexgriandclassicglycemicmetrics
AT fernandezvelascopablo impactofglucosevariabilityontheassessmentoftheglycemiariskindexgriandclassicglycemicmetrics
AT bahillocuriesespilar impactofglucosevariabilityontheassessmentoftheglycemiariskindexgriandclassicglycemicmetrics
AT deluisdaniel impactofglucosevariabilityontheassessmentoftheglycemiariskindexgriandclassicglycemicmetrics
AT diazsotogonzalo impactofglucosevariabilityontheassessmentoftheglycemiariskindexgriandclassicglycemicmetrics